Overview
Aspen is the global leader in aerogel technology. The company's mission is to enable its customers and partners to achieve their own objectives around the global megatrends of resource efficiency and sustainability. Aspen's Cryogel® and Pyrogel® products are valued by the world's largest energy infrastructure companies. Aspen's Spaceloft® products provide building owners with industry-leading energy efficiency and fire safety. The company's PyroThinTM products enable solutions to thermal runaway challenges within the electric vehicle market. The company's carbon aerogel program seeks to increase the performance of lithium-ion battery cells enabling EV OEMs to extend the driving range and reduce the cost of electric vehicles. The company's strategy is to partner with world-class industry leaders to leverage its aerogel technology platform into additional markets. Headquartered in Northborough, Mass., Aspen manufactures its products at its East Providence, R.I. facility.
AI+ Ask Fintel’s AI assistant about Aspen Aerogels, Inc..
Thinking about good questions…
Basic Stats
The share price of Aspen Aerogels, Inc. as of September 5, 2025 is $6.61 / share. This is a decrease of -3.36% from the prior week. The market cap (or net worth) of Aspen Aerogels, Inc. as of September 5, 2025 is $543.69 MM.
The Factor Analysis chart (below right) shows a view of Aspen Aerogels, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 543.69 MM |
| EV | 520.51 MM |
| Shares Out. | 82.25 MM |
| Earnings Date | |
| EPS (TTM) | -3.79 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | 0.41 |
| Short Shares Avail. | 1.10 MM |
| Short Interest | 9.20 MM |
| Short Float | 11.98 % |
| Days to Cover | 7.77 days |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | -74.14 % |
| Volatility (1 yr) | 0.76 |
| Beta | 1.21 |
| Sharpe Ratio (1 yr) | -1.03 |
| Sortino Ratio (1 yr) | -1.60 |
| PE Ratio | -1.75 |
| Price/Book | 1.76 |
| Price/TBV | 1.76 |
| Book/Market | 0.57 |
| EBIT/EV | -0.60 |
| EBIT(3yr avg)/EV | -0.24 |
| ROA | -0.42 |
| ROE | -0.60 |
| ROIC | -0.65 |
| CROIC | 0.16 |
| OCROIC | 0.12 |
| Implied Volatility | 70.44 % |
| Put/Call OI Ratio | 0.16 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Aspen Aerogels, Inc. is $9.77. The forecasts range from a low of $6.06 to a high of $14.70. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Aspen Aerogels, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2022-12-13 | B. Riley Securities | Buy | Maintains | |
| 2022-07-07 | Craig-Hallum | Buy | Maintains | |
| 2022-07-01 | EF Hutton | Buy | Maintains | |
| 2022-05-03 | Canaccord Genuity | Buy | Maintains | |
| 2022-04-29 | EF Hutton | Buy | Maintains | |
| 2022-04-29 | B. Riley Securities | Buy | Maintains | |
| 2022-02-18 | Piper Sandler | Overweight | Maintains | |
| 2022-02-18 | HC Wainwright & Co. | Buy | Maintains | |
| 2021-12-10 | Benchmark | Buy | Initiate | |
| 2021-09-10 | Piper Sandler | Overweight | Initiate | |
| 2021-08-17 | Oppenheimer | Outperform | Initiate | |
| 2021-07-30 | Canaccord Genuity | Buy | Maintains | |
| 2021-07-01 | HC Wainwright & Co. | Neutral | Buy | Upgrade |
| 2021-07-01 | Canaccord Genuity | Buy | Maintains | |
| 2020-10-30 | HC Wainwright & Co. | Buy | Maintains | |
| 2020-09-09 | Northland Capital Markets | Outperform | Initiate | |
| 2020-05-04 | B. Riley FBR | Buy | Maintains | |
| 2020-01-28 | Canaccord Genuity | Buy | Reiterate | |
| 2020-01-23 | B. Riley FBR | Buy | Initiate | |
| 2020-01-23 | B. Riley | Buy | Initiate | |
| 2019-07-22 | H.C. Wainwright | Buy | Initiate | |
| 2016-11-14 | Citigroup | Buy | Neutral | Downgrade |
| 2016-11-04 | Seaport Global | Buy | Neutral | Downgrade |
| 2016-11-04 | JP Morgan | Overweight | Neutral | Downgrade |
| 2016-09-20 | Craig-Hallum | Buy | Initiate | |
| 2016-08-05 | JP Morgan | Overweight | Maintains | |
| 2016-07-07 | Citigroup | Buy | Maintains | |
| 2016-04-14 | KeyBanc | Overweight | Initiate | |
| 2015-11-06 | Canaccord Genuity | Buy | Maintains | |
| 2015-08-12 | Seaport Global | Buy | Initiate | |
| 2015-08-10 | Needham | Buy | Initiate | |
| 2015-08-07 | Canaccord Genuity | Buy | Maintains | |
| 2015-05-29 | JP Morgan | Overweight | Initiate | |
| 2015-03-13 | Citigroup | Buy | Initiate | |
| 2015-02-17 | Baird | Neutral | Outperform | Upgrade |
| 2014-10-16 | ISI Group | Buy | Initiate | |
| 2014-07-08 | JP Morgan | Overweight | Initiate | |
| 2014-07-08 | Citigroup | Neutral | Initiate | |
| 2014-07-08 | Canaccord Genuity | Buy | Initiate | |
| 2014-07-08 | Baird | Neutral | Initiate | |
| 2023-02-17 | Canaccord Genuity | Buy | Maintains | |
| 2023-02-22 | Piper Sandler | Overweight | Maintains | |
| 2023-03-20 | Benchmark | Hold | Buy | Upgrade |
| 2023-06-16 | Canaccord Genuity | Buy | Buy | Reiterate |
| 2023-08-04 | HC Wainwright & Co. | Buy | Buy | Maintains |
| 2024-05-03 | Canaccord Genuity | Buy | Buy | Maintains |
| 2024-05-03 | B. Riley Securities | Buy | Buy | Maintains |
| 2024-05-03 | Roth MKM | Buy | Buy | Reiterate |
| 2024-05-03 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-05-03 | HC Wainwright & Co. | Buy | Buy | Maintains |
| 2024-06-05 | TD Cowen | Buy | Buy | Maintains |
| 2024-03-06 | Roth MKM | Buy | Initiate | |
| 2024-01-16 | HC Wainwright & Co. | Buy | Buy | Maintains |
| 2024-02-14 | HC Wainwright & Co. | Buy | Buy | Reiterate |
| 2024-05-29 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-04-30 | Roth MKM | Buy | Buy | Reiterate |
| 2024-05-14 | Piper Sandler | Overweight | Overweight | Maintains |
| 2023-12-27 | Canaccord Genuity | Buy | Buy | Maintains |
| 2024-06-12 | Roth MKM | Buy | Buy | Reiterate |
| 2024-06-13 | Seaport Global | Buy | Buy | Maintains |
| 2024-06-14 | Craig-Hallum | Buy | Buy | Maintains |
| 2024-11-12 | Barclays | Overweight | Overweight | Maintains |
| 2024-08-21 | Roth MKM | Buy | Buy | Reiterate |
| 2024-08-09 | HC Wainwright & Co. | Buy | Buy | Maintains |
| 2024-08-06 | Barclays | Overweight | Initiate | |
| 2024-11-08 | Roth MKM | Buy | Buy | Maintains |
| 2024-10-16 | HC Wainwright & Co. | Buy | Buy | Reiterate |
| 2024-08-08 | Benchmark | Buy | Buy | Reiterate |
| 2025-01-16 | Canaccord Genuity | Buy | Buy | Maintains |
| 2024-10-22 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-02-14 | Craig-Hallum | Buy | Buy | Maintains |
| 2025-02-14 | Roth MKM | Buy | Buy | Maintains |
| 2025-02-14 | Canaccord Genuity | Buy | Buy | Maintains |
| 2025-05-29 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2025-02-13 | Seaport Global | Buy | Neutral | Downgrade |
| 2024-08-20 | TD Cowen | Buy | Buy | Maintains |
| 2025-02-19 | Barclays | Overweight | Overweight | Maintains |
| 2025-02-19 | B. Riley Securities | Buy | Buy | Maintains |
| 2025-08-08 | Canaccord Genuity | Buy | Buy | Maintains |
| 2025-08-11 | Barclays | Equal-Weight | Underweight | Downgrade |
